Piperazine adenosine monophosphate activated protein kinase (AMPK) agonist and medical application thereof

The invention discloses a piperazine compound with AMPK agonist activity, and a preparation method and medical application of the piperazine compound. The piperazine compound is a compound shown as aformula (I) (please see the specifications for the formula), and a pharmaceutically acceptable salt o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHAO XING, DAI LIANG, YAN DINGFEI, LI MINGLEI, LIU JUN, YAO ZHIYING, CHENG YALONG, HAN LISHUAI, FENG ZHIQI, SUN HONGBIN, ZHANG XIANGYING, ZHAO WENFENG, WANG PENGFEI, CHEN HUI, ZHANG JIA, LIU SHENGJIE, WEN XIAO'AN, WU WENZHEN, SUN GENG, YU SHENGQI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHAO XING
DAI LIANG
YAN DINGFEI
LI MINGLEI
LIU JUN
YAO ZHIYING
CHENG YALONG
HAN LISHUAI
FENG ZHIQI
SUN HONGBIN
ZHANG XIANGYING
ZHAO WENFENG
WANG PENGFEI
CHEN HUI
ZHANG JIA
LIU SHENGJIE
WEN XIAO'AN
WU WENZHEN
SUN GENG
YU SHENGQI
description The invention discloses a piperazine compound with AMPK agonist activity, and a preparation method and medical application of the piperazine compound. The piperazine compound is a compound shown as aformula (I) (please see the specifications for the formula), and a pharmaceutically acceptable salt or ester or a prodrug or N-oxide or solvate thereof. The compound can be used for preparing drugs for preventing or treating AMPK-mediated diseases. 本发明公开了一种具有AMPK激动活性的哌嗪类化合物及其制备方法和医药用途,其为结构式如式(I)所示的化合物、其药学上可接受的盐或酯或前药或N-氧化物或溶剂化物。本发明的化合物可用于制备预防或治疗AMPK介导的疾病的药物。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN110372638A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN110372638A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN110372638A3</originalsourceid><addsrcrecordid>eNqNyjEKwkAQheE0FqLeYey0EIwBtQ1BEURJYR-G7MSMbmaG7GLh6Y3gAazex-MfJ4-SjXp8sxCgI9HwVaei1mqwFuPw15FfAxxYr5FY4MmCgWCRX8rzEvCuwiECioOOHNfoAc38gMgqEFvqSZtpMmrQB5r9dpLMj4dbcVqRaUXBsCahWBXXNF1nu8022-fZP80Ht6dBJA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Piperazine adenosine monophosphate activated protein kinase (AMPK) agonist and medical application thereof</title><source>esp@cenet</source><creator>ZHAO XING ; DAI LIANG ; YAN DINGFEI ; LI MINGLEI ; LIU JUN ; YAO ZHIYING ; CHENG YALONG ; HAN LISHUAI ; FENG ZHIQI ; SUN HONGBIN ; ZHANG XIANGYING ; ZHAO WENFENG ; WANG PENGFEI ; CHEN HUI ; ZHANG JIA ; LIU SHENGJIE ; WEN XIAO'AN ; WU WENZHEN ; SUN GENG ; YU SHENGQI</creator><creatorcontrib>ZHAO XING ; DAI LIANG ; YAN DINGFEI ; LI MINGLEI ; LIU JUN ; YAO ZHIYING ; CHENG YALONG ; HAN LISHUAI ; FENG ZHIQI ; SUN HONGBIN ; ZHANG XIANGYING ; ZHAO WENFENG ; WANG PENGFEI ; CHEN HUI ; ZHANG JIA ; LIU SHENGJIE ; WEN XIAO'AN ; WU WENZHEN ; SUN GENG ; YU SHENGQI</creatorcontrib><description>The invention discloses a piperazine compound with AMPK agonist activity, and a preparation method and medical application of the piperazine compound. The piperazine compound is a compound shown as aformula (I) (please see the specifications for the formula), and a pharmaceutically acceptable salt or ester or a prodrug or N-oxide or solvate thereof. The compound can be used for preparing drugs for preventing or treating AMPK-mediated diseases. 本发明公开了一种具有AMPK激动活性的哌嗪类化合物及其制备方法和医药用途,其为结构式如式(I)所示的化合物、其药学上可接受的盐或酯或前药或N-氧化物或溶剂化物。本发明的化合物可用于制备预防或治疗AMPK介导的疾病的药物。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191025&amp;DB=EPODOC&amp;CC=CN&amp;NR=110372638A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191025&amp;DB=EPODOC&amp;CC=CN&amp;NR=110372638A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHAO XING</creatorcontrib><creatorcontrib>DAI LIANG</creatorcontrib><creatorcontrib>YAN DINGFEI</creatorcontrib><creatorcontrib>LI MINGLEI</creatorcontrib><creatorcontrib>LIU JUN</creatorcontrib><creatorcontrib>YAO ZHIYING</creatorcontrib><creatorcontrib>CHENG YALONG</creatorcontrib><creatorcontrib>HAN LISHUAI</creatorcontrib><creatorcontrib>FENG ZHIQI</creatorcontrib><creatorcontrib>SUN HONGBIN</creatorcontrib><creatorcontrib>ZHANG XIANGYING</creatorcontrib><creatorcontrib>ZHAO WENFENG</creatorcontrib><creatorcontrib>WANG PENGFEI</creatorcontrib><creatorcontrib>CHEN HUI</creatorcontrib><creatorcontrib>ZHANG JIA</creatorcontrib><creatorcontrib>LIU SHENGJIE</creatorcontrib><creatorcontrib>WEN XIAO'AN</creatorcontrib><creatorcontrib>WU WENZHEN</creatorcontrib><creatorcontrib>SUN GENG</creatorcontrib><creatorcontrib>YU SHENGQI</creatorcontrib><title>Piperazine adenosine monophosphate activated protein kinase (AMPK) agonist and medical application thereof</title><description>The invention discloses a piperazine compound with AMPK agonist activity, and a preparation method and medical application of the piperazine compound. The piperazine compound is a compound shown as aformula (I) (please see the specifications for the formula), and a pharmaceutically acceptable salt or ester or a prodrug or N-oxide or solvate thereof. The compound can be used for preparing drugs for preventing or treating AMPK-mediated diseases. 本发明公开了一种具有AMPK激动活性的哌嗪类化合物及其制备方法和医药用途,其为结构式如式(I)所示的化合物、其药学上可接受的盐或酯或前药或N-氧化物或溶剂化物。本发明的化合物可用于制备预防或治疗AMPK介导的疾病的药物。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwkAQheE0FqLeYey0EIwBtQ1BEURJYR-G7MSMbmaG7GLh6Y3gAazex-MfJ4-SjXp8sxCgI9HwVaei1mqwFuPw15FfAxxYr5FY4MmCgWCRX8rzEvCuwiECioOOHNfoAc38gMgqEFvqSZtpMmrQB5r9dpLMj4dbcVqRaUXBsCahWBXXNF1nu8022-fZP80Ht6dBJA</recordid><startdate>20191025</startdate><enddate>20191025</enddate><creator>ZHAO XING</creator><creator>DAI LIANG</creator><creator>YAN DINGFEI</creator><creator>LI MINGLEI</creator><creator>LIU JUN</creator><creator>YAO ZHIYING</creator><creator>CHENG YALONG</creator><creator>HAN LISHUAI</creator><creator>FENG ZHIQI</creator><creator>SUN HONGBIN</creator><creator>ZHANG XIANGYING</creator><creator>ZHAO WENFENG</creator><creator>WANG PENGFEI</creator><creator>CHEN HUI</creator><creator>ZHANG JIA</creator><creator>LIU SHENGJIE</creator><creator>WEN XIAO'AN</creator><creator>WU WENZHEN</creator><creator>SUN GENG</creator><creator>YU SHENGQI</creator><scope>EVB</scope></search><sort><creationdate>20191025</creationdate><title>Piperazine adenosine monophosphate activated protein kinase (AMPK) agonist and medical application thereof</title><author>ZHAO XING ; DAI LIANG ; YAN DINGFEI ; LI MINGLEI ; LIU JUN ; YAO ZHIYING ; CHENG YALONG ; HAN LISHUAI ; FENG ZHIQI ; SUN HONGBIN ; ZHANG XIANGYING ; ZHAO WENFENG ; WANG PENGFEI ; CHEN HUI ; ZHANG JIA ; LIU SHENGJIE ; WEN XIAO'AN ; WU WENZHEN ; SUN GENG ; YU SHENGQI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN110372638A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHAO XING</creatorcontrib><creatorcontrib>DAI LIANG</creatorcontrib><creatorcontrib>YAN DINGFEI</creatorcontrib><creatorcontrib>LI MINGLEI</creatorcontrib><creatorcontrib>LIU JUN</creatorcontrib><creatorcontrib>YAO ZHIYING</creatorcontrib><creatorcontrib>CHENG YALONG</creatorcontrib><creatorcontrib>HAN LISHUAI</creatorcontrib><creatorcontrib>FENG ZHIQI</creatorcontrib><creatorcontrib>SUN HONGBIN</creatorcontrib><creatorcontrib>ZHANG XIANGYING</creatorcontrib><creatorcontrib>ZHAO WENFENG</creatorcontrib><creatorcontrib>WANG PENGFEI</creatorcontrib><creatorcontrib>CHEN HUI</creatorcontrib><creatorcontrib>ZHANG JIA</creatorcontrib><creatorcontrib>LIU SHENGJIE</creatorcontrib><creatorcontrib>WEN XIAO'AN</creatorcontrib><creatorcontrib>WU WENZHEN</creatorcontrib><creatorcontrib>SUN GENG</creatorcontrib><creatorcontrib>YU SHENGQI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHAO XING</au><au>DAI LIANG</au><au>YAN DINGFEI</au><au>LI MINGLEI</au><au>LIU JUN</au><au>YAO ZHIYING</au><au>CHENG YALONG</au><au>HAN LISHUAI</au><au>FENG ZHIQI</au><au>SUN HONGBIN</au><au>ZHANG XIANGYING</au><au>ZHAO WENFENG</au><au>WANG PENGFEI</au><au>CHEN HUI</au><au>ZHANG JIA</au><au>LIU SHENGJIE</au><au>WEN XIAO'AN</au><au>WU WENZHEN</au><au>SUN GENG</au><au>YU SHENGQI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Piperazine adenosine monophosphate activated protein kinase (AMPK) agonist and medical application thereof</title><date>2019-10-25</date><risdate>2019</risdate><abstract>The invention discloses a piperazine compound with AMPK agonist activity, and a preparation method and medical application of the piperazine compound. The piperazine compound is a compound shown as aformula (I) (please see the specifications for the formula), and a pharmaceutically acceptable salt or ester or a prodrug or N-oxide or solvate thereof. The compound can be used for preparing drugs for preventing or treating AMPK-mediated diseases. 本发明公开了一种具有AMPK激动活性的哌嗪类化合物及其制备方法和医药用途,其为结构式如式(I)所示的化合物、其药学上可接受的盐或酯或前药或N-氧化物或溶剂化物。本发明的化合物可用于制备预防或治疗AMPK介导的疾病的药物。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN110372638A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Piperazine adenosine monophosphate activated protein kinase (AMPK) agonist and medical application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A50%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHAO%20XING&rft.date=2019-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN110372638A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true